• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Angina Pectoris: Review and Update - Parts 1 & 2

Program Type

Monograph

Credits

1.5 Contact Hour(s)

Release Date

Tuesday, February 19, 2019

Offline Date:

Thursday, August 19, 2021

ACPE Expiration Date

Saturday, February 19, 2022

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$6.00

  • Overview

    Angina pectoris is the term for chest pain or discomfort due to coronary heart disease. It is a symptom of a condition called myocardial ischemia. In part 1 and 2, we will discuss a number of factors related to treatment of angina pectoris. Background descriptions and classification of the disease are discussed in Part 1. Also, in part 1, we provide a detailed synopsis of organic nitrate therapy. In part 2, we will provide explanations and information regarding the other 3 classes of angina medications, along with summaries of therapeutic treatment rationale.

    Handouts

    Homestudy PDF:   19025H01.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    List determinants of myocardial oxygen demand and myocardial oxygen supply
    Describe the pharmacology of antianginal medications
    Prepare a pharmacotherapeutic plan to prevent stable angina and variant angina from occurring
    Identify common adverse effects of antianginal drugs
    Describe angina treatment using beta-receptor blockers, calcium channel blockers and ranolazine
    Discuss pharmacotherapeutic approaches to angina therapy
    List the rationale for using non-pharmacological treatments, SL nitroglycerin, and dual platelet therapy for angina
    Describe an approach for treating unstable angina


    Pharmacist

    List determinants of myocardial oxygen demand and myocardial oxygen supply
    Describe the pharmacology of antianginal medications
    Prepare a pharmacotherapeutic plan to prevent stable angina and variant angina from occurring
    Identify common adverse effects of antianginal drugs
    Counsel patients when dispensing SL nitroglycerin drugs
    Describe angina treatment using beta-receptor blockers, calcium channel blockers and ranolazine
    Discuss pharmacotherapeutic approaches to angina therapy
    List the rationale for using non-pharmacological treatments, SL nitroglycerin, and dual platelet therapy for angina
    Describe an approach for treating unstable angina


    Pharmacy Technician

    List determinants of myocardial oxygen demand and myocardial oxygen supply
    Describe the pharmacology of antianginal medications
    Identify common adverse effects of antianginal drugs
    Describe angina treatment using beta-receptor blockers, calcium channel blockers and ranolazine
    Discuss pharmacotherapeutic approaches to angina therapy
    List the rationale for using non-pharmacological treatments, SL nitroglycerin, and dual platelet therapy for angina
    Describe an approach for treating unstable angina

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-19-025-H01-N

    Pharmacist 0798-0000-19-025-H01-P

    Pharmacy Technician 0798-0000-19-025-H01-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

  • Faculty

    Vincent Mauro, PharmD
    Professor, Clinical Pharmacy University of Toledo, College of Pharmacy and Pharmaceutical Sciences; Adjunct Professor of Medicine, University of Toledo, College of Medicine & Life Sciences




HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher
Adobe Acrobat Reader


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.